Financials
Financial year 2025
PHARMACIE DELVIGNE DOUMONT from Genappe, company number BE0473801448, closed financial year 2025 with a result of € 66,530 after tax. For that financial year PHARMACIE DELVIGNE DOUMONT recorded a gross margin of € 189,736 and equity of € 188,029. Compared with financial year 2024, the result moved from € 103,905 to € 66,530. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 188,029
▲ 55% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 66,530
▼ 36% vs 2024
Profit after tax over the fiscal year.
€ 164,871
▲ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 125,981.
People and assets in 2025
1.7
Average over the fiscal year, from the social balance sheet.
€ 77,461
▲ 1% vs 2024
€ 45,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,736
▼ 44% vs 2024
Of which on lease € 432.
Debts at end 2025
€ 73,301
▼ 13% vs 2024
€ 11,879 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 157,289
▲ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,183
▼ 22% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 174,948 | € 211,290 | € 239,138 | € 189,736 | ▼ 21% |
| Profit after taxes | € 41,007 | € -453,745 | € 103,905 | € 66,530 | ▼ 36% |
| Equity | € 486,340 | € 32,595 | € 121,500 | € 188,029 | ▲ 55% |
| Total debts | € 1,498,287 | € 361,527 | € 288,089 | € 263,658 | ▼ 8% |
| Cash | € 80,195 | € 159,369 | € 152,968 | € 164,871 | ▲ 8% |
| Land & buildings | € 53,896 | € 49,043 | € 44,190 | € 39,336 | ▼ 11% |
| Retained profit | € 424,292 | € -29,454 | € 59,452 | € 125,981 | ▲ 112% |
| Dividend | € 0 | € 0 | € 15,000 | € 0 | ▼ 100% |
| Bank debt | € 823,425 | € 100,791 | € 84,684 | € 73,301 | ▼ 13% |
| Balance sheet total | € 1,984,627 | € 394,122 | € 409,589 | € 451,687 | ▲ 10% |
| Employees (FTE) | 1.7 | 1.7 | 1.7 | 1.7 |
Key figures of PHARMACIE DELVIGNE DOUMONT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DELVIGNE DOUMONT?
What happened at PHARMACIE DELVIGNE DOUMONT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- CORINNE DELVIGNE stepped down as director. NBB
- RENAUD DOUMONT stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 66,530 (▼ 36% vs 2024). Source: NBB ↗
- CORINNE DELVIGNE became a director. NBB
- RENAUD DOUMONT became a director. NBB
- New establishment in Genappe. KBO
- Start of the company according to the CBE. KBO
In short
From € 41,007 profit in 2022 to € 66,530 profit in 2025.
Paid € 96,177 in corporate taxes since 2022.
Best year ever: 2024, with € 103,905 profit.
On average € 111,600 of value added per employee in 2025.
A new publication or filing at PHARMACIE DELVIGNE DOUMONT? We notify you, reason included.
Follow PHARMACIE DELVIGNE DOUMONTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
CORINNE DELVIGNE
Managing director
since 2014 · until 2029
since 2014 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue de Bruxelles 47
1470 Genappe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0473.801.448
- VAT number
- BE 0473.801.448
- Registered office
- Rue de Bruxelles 47, 1470 Genappe
- Names & denominations
- PHARMACIE DELVIGNE DOUMONT · DOUDEL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2001
- Peppol
- Active · Active since 12 Jun 2024
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers